Literature DB >> 20206017

Imaging primary lung cancers in mice to study radiation biology.

David G Kirsch1, Jan Grimm, Alexander R Guimaraes, Gregory R Wojtkiewicz, Bradford A Perez, Philip M Santiago, Nikolas K Anthony, Thomas Forbes, Karen Doppke, Ralph Weissleder, Tyler Jacks.   

Abstract

PURPOSE: To image a genetically engineered mouse model of non-small-cell lung cancer with micro-computed tomography (micro-CT) to measure tumor response to radiation therapy. METHODS AND MATERIALS: The Cre-loxP system was used to generate primary lung cancers in mice with mutation in K-ras alone or in combination with p53 mutation. Mice were serially imaged by micro-CT, and tumor volumes were determined. A comparison of tumor volume by micro-CT and tumor histology was performed. Tumor response to radiation therapy (15.5 Gy) was assessed with micro-CT.
RESULTS: The tumor volume measured with free-breathing micro-CT scans was greater than the volume calculated by histology. Nevertheless, this imaging approach demonstrated that lung cancers with mutant p53 grew more rapidly than lung tumors with wild-type p53 and also showed that radiation therapy increased the doubling time of p53 mutant lung cancers fivefold.
CONCLUSIONS: Micro-CT is an effective tool to noninvasively measure the growth of primary lung cancers in genetically engineered mice and assess tumor response to radiation therapy. This imaging approach will be useful to study the radiation biology of lung cancer. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20206017      PMCID: PMC2847457          DOI: 10.1016/j.ijrobp.2009.11.038

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  14 in total

Review 1.  Animal systems for translational research in radiation oncology.

Authors:  A G Taghian; H D Suit
Journal:  Acta Oncol       Date:  1999       Impact factor: 4.089

2.  Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study.

Authors:  Achilles J Fakiris; Ronald C McGarry; Constantin T Yiannoutsos; Lech Papiez; Mark Williams; Mark A Henderson; Robert Timmerman
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-02-27       Impact factor: 7.038

3.  Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras.

Authors:  E L Jackson; N Willis; K Mercer; R T Bronson; D Crowley; R Montoya; T Jacks; D A Tuveson
Journal:  Genes Dev       Date:  2001-12-15       Impact factor: 11.361

4.  Lung cancer rates convergence in young men and women in the United States: analysis by birth cohort and histologic type.

Authors:  Ahmedin Jemal; William D Travis; Robert E Tarone; Lois Travis; Susan S Devesa
Journal:  Int J Cancer       Date:  2003-05-20       Impact factor: 7.396

5.  An oncogenic KRAS2 expression signature identified by cross-species gene-expression analysis.

Authors:  Alejandro Sweet-Cordero; Sayan Mukherjee; Aravind Subramanian; Han You; Jeffrey J Roix; Christine Ladd-Acosta; Jill Mesirov; Todd R Golub; Tyler Jacks
Journal:  Nat Genet       Date:  2004-12-19       Impact factor: 38.330

6.  Responses to antiangiogenesis treatment of spontaneous autochthonous tumors and their isografts.

Authors:  Yotaro Izumi; Emmanuelle di Tomaso; Andrea Hooper; Peigen Huang; James Huber; Daniel J Hicklin; Dai Fukumura; Rakesh K Jain; Herman D Suit
Journal:  Cancer Res       Date:  2003-02-15       Impact factor: 12.701

7.  Tumor response to radiotherapy regulated by endothelial cell apoptosis.

Authors:  Monica Garcia-Barros; Francois Paris; Carlos Cordon-Cardo; David Lyden; Shahin Rafii; Adriana Haimovitz-Friedman; Zvi Fuks; Richard Kolesnick
Journal:  Science       Date:  2003-05-16       Impact factor: 47.728

8.  Cancer statistics, 2009.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2009-05-27       Impact factor: 508.702

9.  Somatic mutations affect key pathways in lung adenocarcinoma.

Authors:  Li Ding; Gad Getz; David A Wheeler; Elaine R Mardis; Michael D McLellan; Kristian Cibulskis; Carrie Sougnez; Heidi Greulich; Donna M Muzny; Margaret B Morgan; Lucinda Fulton; Robert S Fulton; Qunyuan Zhang; Michael C Wendl; Michael S Lawrence; David E Larson; Ken Chen; David J Dooling; Aniko Sabo; Alicia C Hawes; Hua Shen; Shalini N Jhangiani; Lora R Lewis; Otis Hall; Yiming Zhu; Tittu Mathew; Yanru Ren; Jiqiang Yao; Steven E Scherer; Kerstin Clerc; Ginger A Metcalf; Brian Ng; Aleksandar Milosavljevic; Manuel L Gonzalez-Garay; John R Osborne; Rick Meyer; Xiaoqi Shi; Yuzhu Tang; Daniel C Koboldt; Ling Lin; Rachel Abbott; Tracie L Miner; Craig Pohl; Ginger Fewell; Carrie Haipek; Heather Schmidt; Brian H Dunford-Shore; Aldi Kraja; Seth D Crosby; Christopher S Sawyer; Tammi Vickery; Sacha Sander; Jody Robinson; Wendy Winckler; Jennifer Baldwin; Lucian R Chirieac; Amit Dutt; Tim Fennell; Megan Hanna; Bruce E Johnson; Robert C Onofrio; Roman K Thomas; Giovanni Tonon; Barbara A Weir; Xiaojun Zhao; Liuda Ziaugra; Michael C Zody; Thomas Giordano; Mark B Orringer; Jack A Roth; Margaret R Spitz; Ignacio I Wistuba; Bradley Ozenberger; Peter J Good; Andrew C Chang; David G Beer; Mark A Watson; Marc Ladanyi; Stephen Broderick; Akihiko Yoshizawa; William D Travis; William Pao; Michael A Province; George M Weinstock; Harold E Varmus; Stacey B Gabriel; Eric S Lander; Richard A Gibbs; Matthew Meyerson; Richard K Wilson
Journal:  Nature       Date:  2008-10-23       Impact factor: 49.962

10.  Dosimetric evaluation of heterogeneity corrections for RTOG 0236: stereotactic body radiotherapy of inoperable stage I-II non-small-cell lung cancer.

Authors:  Ying Xiao; Lech Papiez; Rebecca Paulus; Robert Timmerman; William L Straube; Walter R Bosch; Jeff Michalski; James M Galvin
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-03-15       Impact factor: 7.038

View more
  33 in total

1.  Commissioning a small-field biological irradiator using point, 2D, and 3D dosimetry techniques.

Authors:  Joseph Newton; Mark Oldham; Andrew Thomas; Yifan Li; John Adamovics; David G Kirsch; Shiva Das
Journal:  Med Phys       Date:  2011-12       Impact factor: 4.071

2.  Quantitative analysis of tumor burden in mouse lung via MRI.

Authors:  Vanessa K Tidwell; Joel R Garbow; Alexander S Krupnick; John A Engelbach; Arye Nehorai
Journal:  Magn Reson Med       Date:  2011-09-27       Impact factor: 4.668

3.  Imaging primary lung cancers in mice to study radiation biology: in regard to Kirsch et al. (Int J Radiat Oncol Biol Phys 2010;76:973-977).

Authors:  Joel R Garbow; Joseph J H Ackerman
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-03-01       Impact factor: 7.038

Review 4.  Lessons learned from radiation oncology clinical trials.

Authors:  Fei-Fei Liu; Paul Okunieff; Eric J Bernhard; Helen B Stone; Stephen Yoo; C Norman Coleman; Bhadrasain Vikram; Martin Brown; John Buatti; Chandan Guha
Journal:  Clin Cancer Res       Date:  2013-09-16       Impact factor: 12.531

5.  Pre-clinical imaging for establishment and comparison of orthotopic non-small cell lung carcinoma: in search for models reflecting clinical scenarios.

Authors:  Rozina Aktar; Antje Dietrich; Falk Tillner; Shady Kotb; Steffen Löck; Henning Willers; Michael Baumann; Mechthild Krause; Rebecca Bütof
Journal:  Br J Radiol       Date:  2018-10-11       Impact factor: 3.039

6.  Genetically engineered mouse models for studying radiation biology.

Authors:  Katherine D Castle; Mark Chen; Amy J Wisdom; David G Kirsch
Journal:  Transl Cancer Res       Date:  2017-07       Impact factor: 1.241

7.  Using genetically engineered mice for radiation research.

Authors:  David G Kirsch
Journal:  Radiat Res       Date:  2011-09       Impact factor: 2.841

8.  Contrast agents for quantitative microCT of lung tumors in mice.

Authors:  Kush Lalwani; Anand Giddabasappa; Danan Li; Peter Olson; Brett Simmons; Farbod Shojaei; Todd Van Arsdale; James Christensen; Amy Jackson-Fisher; Anthony Wong; Patrick B Lappin; Jeetendra Eswaraka
Journal:  Comp Med       Date:  2013       Impact factor: 0.982

9.  Establishment of an orthotopic lung cancer model in nude mice and its evaluation by spiral CT.

Authors:  Xiang Liu; Jun Liu; Yubao Guan; Huiling Li; Liyan Huang; Hailing Tang; Jianxing He
Journal:  J Thorac Dis       Date:  2012-04-01       Impact factor: 2.895

10.  SWIFT MRI enhances detection of breast cancer metastasis to the lung.

Authors:  Naoharu Kobayashi; Djaudat Idiyatullin; Curt Corum; Joseph Weber; Michael Garwood; Deepali Sachdev
Journal:  Magn Reson Med       Date:  2014-06-11       Impact factor: 4.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.